Berkowitz Noah 4
4 · ARVINAS, INC. · Filed Mar 19, 2026
Research Summary
AI-generated summary of this filing
ARVINAS (ARVN) CMO Noah Berkowitz Sells Shares
What Happened
Noah Berkowitz, Chief Medical Officer of Arvinas, sold 6,435 shares on March 18, 2026 at $11.10 per share, generating proceeds of $71,431. The filing indicates this was an automatic sale to satisfy tax withholding tied to the vesting and settlement of 25% of RSUs granted March 18, 2024, and not a discretionary trade.
Key Details
- Transaction date: 2026-03-18; Price: $11.10; Shares sold: 6,435; Proceeds: $71,431. (Transaction code: S = Sale)
- Footnote: The sale was automatic by the issuer to cover tax withholding obligations on vested RSUs (footnote F1); it does not represent a discretionary trade.
- Shares owned after the transaction: not disclosed in this Form 4.
- Filing: Form 4 filed 2026-03-19 (timely; filed within one business day of the transaction).
Context
Automatic withholding sales on RSU vesting are common and are executed to satisfy tax obligations; they are routine and generally not considered a signal of negative insider sentiment. Purchases or voluntary sales by insiders tend to be more informative about their view of the company.
Insider Transaction Report
Form 4
ARVINAS, INC.ARVN
Berkowitz Noah
Chief Medical Officer
Transactions
- Sale
Common Stock
[F1]2026-03-18$11.10/sh−6,435$71,431→ 202,503 total
Footnotes (1)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of 25% of the reporting person's restricted stock units (RSUs) granted on March 18, 2024. The sale does not represent a discretionary trade.
Signature
/s/ Jared Freedberg, as attorney-in-fact for Noah Berkowitz|2026-03-19